Turkish Validity and Reliability of the Social Frailty Index

April 24, 2024 updated by: Elif Gur Kabul, Pamukkale University

Turkish Validity and Reliability of the Social Frailty Index in the Older Adults

The aim was to examine the validity and reliability of the Social Frailty Index in Turkish among older adults. 65 years and above older adults will be included included in the study. Older adults who agree to participate in the study will first be administered the Hodkinson Mental Test. Those who score 6 points and above will be included in the study. To evaluate the validity of the "Social Frailty Index", Social Inclusion Scale, Older people's quality of life-brief (OPQOL-brief) and Lubben Social Network Scale will be applied to the participants. To determine the reliability of the "Social Frailty Index", older adults who do not receive any treatment will be tested and re-tested at one-week intervals.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

186

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Usak, Merkez, Turkey, 64200
        • Elif Gur Kabul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Getting a score of 6 or above on the Hodkinson Mental Test

Exclusion Criteria:

  • -Having another chronic disease that can cause pain
  • Having a neurological disease
  • Being blind
  • Having an orthopedic, neurological or mental disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
65 years and above older adults
Social Frailty Index will be applied twice, one week apart.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Frailty Index
Time Frame: 10 minutes
Social Frailty Index included age, gender and eight social predictors
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socıal Inclusıon Scale
Time Frame: 10 minutes
It consists of 22 items
10 minutes
Older people's quality of life-brief (OPQOL-brief)
Time Frame: 8 minutes
It consists of 13 items
8 minutes
Lubben Social Network Scale
Time Frame: 5 minutes
It consists of 6 items
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2024

Primary Completion (Actual)

March 20, 2024

Study Completion (Actual)

March 30, 2024

Study Registration Dates

First Submitted

February 24, 2024

First Submitted That Met QC Criteria

February 24, 2024

First Posted (Actual)

March 1, 2024

Study Record Updates

Last Update Posted (Actual)

April 25, 2024

Last Update Submitted That Met QC Criteria

April 24, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SFI-TR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Social Frailty Index

Subscribe